Medical Equipment, Supplies & Distribution

Page 1

Eternity Healthcare and Shanghai Yin Jun Investment & Development establish joint venture operation for US$3 mln

8:01am EDT

Eternity Healthcare Inc:Says it has signed an agreement with Shanghai Yin Jun Investment & Development Inc., to establish a Joint Venture manufacturing operation in China.Shanghai Yin Jun to invest initially US$3 mln dollars into the Joint Venture company.Eternity Healthcare, Inc. will be responsible for clinical trials, regulatory approval and marketing of the product worldwide.JV Company will manufacture certain medical devices that have mass marketing appeal, with the possibility of having several million dollars in sales annually.

MiMedx Group Inc files its initial investigational new drug application

7:59am EDT

MiMedx Group Inc:Filed its initial Investigational New Drug (IND) application with the Food and Drug Administration (FDA).Says IND submission, which was filed, July 22 is the Company's initial submission for certain indications of its micronized allografts towards targeted Biologics License Applications (BLAs).As communicated in the Company's Dec. 4, 2013 press release, this IND filing is first major milestone in process, which is expected to culminate in at least two separate BLAs for certain indications of the Company's micronized allografts.

CONMED Corp lowers FY 2014 outlook

7:02am EDT

CONMED Corp:Expects FY 2014 sales to be in the range of $735 - $745 mln, compared to prior guidance of $770-780 mln.Expects FY 2014 earnings per share to be in the range $1.85 - $1.95 compared to prior guidance of $1.90 - $2.00.FY 2014 revenue of $766 mln, EPS of $1.94 - Thomson Reuters I/B/E/S.

CONMED Corp announces change in CEO and President stepping down

7:00am EDT

CONMED Corp:Says Joseph Corasanti is stepping down as Chief Executive Officer, President and member of the Board of Directors, effective immediately.Board has appointed Curt Hartman, an independent director of CONMED as Interim Chief Executive Officer.

KAWAMOTO CORP to sell property and expects extraordinary profit for FY 2015

3:00am EDT

KAWAMOTO CORP:To sell a Tokyo-based property to a Japan-based company, for 330 million yen on Aug. 28.Expects extraordinary profit of 109 million yen as gain from selling of property for FY ending March 2015.

Stratec Biomedical AG confirms FY 2014 outlook and confirms medium-term financial forecast for years through to 2017

1:35am EDT

Stratec Biomedical AG:Continues to expect for FY 2014 substantial sales growth compared with FY 2013 financial, accompanied by slight increase in EBIT margin.Says medium-term financial forecast for years through to 2017 provides for average annual sales growth of 8 pct to 12 pct based on volume of sales generated in FY 2013.

Biomerieux SA's Virtuo receives CE-mark

1:00am EDT

Biomerieux SA:Announces that Virtuo, part of BacT/ALERT product range, has been CE-marked.Virtuo is automated blood culture microbial detection system.

St. Jude Medical Inc announces CE Mark approval and first use of FlexAbility Ablation Catheter

Tuesday, 22 Jul 2014 08:00am EDT

St. Jude Medical Inc:Says CE Mark approval and first use of FlexAbility Ablation Catheter, novel ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias.Designed with feedback from physician thought-leaders around world, FlexAbility catheter combines a unique, irrigated flexible catheter tip with a state-of-the-art handle and catheter design.Next-generation flexible tip technology was designed to reduce complications associated with ablation procedures through ability to bend and conform to cardiac anatomy, decreasing amount of pressure distributed to patient's heart wall while simultaneously increasing the stability of therapy delivery.European approval of FlexAbility ablation catheter further strengthens St. Jude Medical's fast-growing ablation technology portfolio.

Teleflex Inc receives FDA clearance for ARROW-Clark VectorFlow Chronic Hemodialysis Catheter

Tuesday, 22 Jul 2014 07:00am EDT

Teleflex Inc:Receives FDA 510(K) clearance to market its ARROW-Clark VectorFlow Chronic Hemodialysis Catheter.VectorFlow Catheter features a symmetrical tip design that allows ease of placement and sustained high flows with minimal recirculation.

Sartorius AG confirms FY 2014 revenue guidance

Tuesday, 22 Jul 2014 01:00am EDT

Sartorius AG:Confirms forecast for FY 2014, which projects currency-adjusted growth in sales of 8 pct. to 10 pct.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Zacks Investment Research Inc.
$10.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.